Tech stocks led the way, guided by Microsoft Corp.'s (MSFT) 3.99 percent gain for a closing price of $29.73, followed by Intel Corp. (INTC), up 3.32 percent to $21.79. Cisco Systems (CSCO), Hewlett-Packard (HPQ), and AT&T (T) were also among the Dow’s best performers.
Aerospace and defense giant Boeing (BA) received a small bump of 0.58 percent to close at $87.52, after the company announced the return of it problem-plagued 787 Dreamliner as early as next month. Boeing also announced a $1 billion investment to expand its South Carolina 787 factory, in the way of a similar announcement yesterday from its major rival Airbus regarding the opening of its first U.S. factory in Alabama.
The S&P 500 moved to within points of its all-time high during the day, hitting 1,573.89 before pulling back to 1,568.61, a gain of 0.35 percent, led by First Solar Inc. (FSLR), whose shares almost doubled (up 45.53 percent) to $39.35 after the company announced guidance figures for the rest of the year of between $4 and $4.50 per share earnings that were well in excess of analyst forecasts of $3.51 per share. The company’s share price seems to have benefited from the effects of a short-squeeze, as well as Monday evening rumors that Warren Buffet was looking in to an acquisition of First Solar’s beleaguered Chinese rival Suntech Power (STP).
Tech stocks also figured heavily into the S&P’s rally, with Microsoft, Intel, Seagate Technology (STX), and Western Digital (WDC) all recording gains of 3 percent or higher. Meanwhile services provided the downward pressure, headed by J.C. Penney (JCP), whose shares dropped over 12 percent to close the day at $13.93, after the company forced the resignation of Ron Johnson on Monday and replaced him with former CEO Mike Ullman.
Darden Restaurants (DRI), Abercrombie & Fitch (ANF), Dollar Tree (DLTR) and CarMax Inc. (KMX) all posted losses between 1.5 and 3 percent.
The Nasdaq closed up 0.48 percent to 3,237.86, with certain health care stocks doing particularly well: Sarepta Therapeutics (SRPT) up 11.16 percent to $39.85, Repros Therapeutics (RPRX) up 6.53 percent to $16.32, and Magellan Health Services (MGLN) up 2.75 percent to $51.20.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer